Experts say, however, there’s no reason to panic.
The new collaboration pledges a combined $200 million to find affordable, globally-available gene-based solutions.
Some men may be at a 10 times higher risk of cancer, and researchers are determined to find out why.
The CD11+c cell is on the frontline of the body’s response to HIV, and new research provides promise for treatment.
ViiV Healthcare makes progress in developing a monthly injectable to treat HIV.
The gene editing technique is highly controversial, but could it be worth it?
The disease which HIV once claimed many victims to is close to a working treatment.